Results 111 to 120 of about 8,075,360 (336)
A GROWTH INHIBITORY SUBSTANCE FOR THE INFLUENZA GROUP OF ORGANISMS IN THE BLOOD OF VARIOUS ANIMAL SPECIES [PDF]
Elma Krumwiede, Ann G. Kuttner
openalex +1 more source
Study of the effect of plant growth regulators, size, and cultivar of the grape inflorescence explant on production of phenolic compounds in an in vitro condition [PDF]
Introduction: Phenolic compounds are a large number of secondary metabolites that have useful and desirable effects in the field of agriculture, medicine, and food.
Gholami, M. +3 more
core
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
NOTE ON THE FAT-SOLUBLE GROWTH-PROMOTING SUBSTANCE IN LARD AND COTTON-SEED OIL
A. L. Daniels, Rosemary Loughlin
openalex +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
The Substitution of Complexing Substances for Boron in Plant Growth
J. R. Skok
openalex +2 more sources
THE PRECIPITATION OF MAGNESIUM AMMONIUM PHOSPHATE CRYSTALS DURING THE GROWTH OF BACTERIA IN MEDIA CONTAINING NITROGENOUS SUBSTANCES [PDF]
Sara A. Scudder
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source

